Seibold, James R https://orcid.org/0000-0001-5187-3141
Maher, Toby M
Highland, Kristin B
Assassi, Shervin https://orcid.org/0000-0002-8059-9978
Azuma, Arata
Hummers, Laura Kathleen
Costabel, Ulrich
von Wangenheim, Ute
Kohlbrenner, Veronika
Gahlemann, Martina
Alves, Margarida
Distler, Oliver https://orcid.org/0000-0002-0546-8310
Funding for this research was provided by:
The SENSCIS trial was funded by Boehringer Ingelheim.
This article is maintained by: Elsevier
Article Title: Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
Journal Title: Annals of the Rheumatic Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2020-217331
Content Type: article
Copyright: Copyright © 2020 © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.